August 8th, 2018: Understanding and Remembrance Day for Severe ME
Have you heard of our Severe Myalgic Encephalomyelitis Day of Understanding and Remembrance? Please join Jody Smith in observing this day and honoring the 25% of those with ME/CFS who are most severely ill.
Discuss the article on the Forums.

KL1333, orphan drug approved for the treatment of mitochondrial disorders

Discussion in 'Other Health News and Research' started by Ema, May 4, 2018.

  1. Ema

    Ema Senior Member

    Messages:
    4,688
    Likes:
    6,823
    Midwest USA
    “KL1333 is a potent regulator of the cellular levels of NAD+, a key molecule in the cell’s energy metabolism. In preclinical studies, KL1333 was able to increase mitochondrial energy levels, reduce the formation and accumulation of toxic compounds (e.g., lactate and free radicals), and induce the formation of new mitochondria.”

    https://mitochondrialdiseasenews.co...rphan-drug-status-mitochondrial-diseases/?amp
     
    Mary, junkcrap50, alkt and 2 others like this.
  2. nanonug

    nanonug Senior Member

    Messages:
    1,664
    Likes:
    1,128
    Virginia, USA
    Awesome! Looking forward to put my hands on this when available.
     
    Ema and alkt like this.
  3. HowToEscape?

    HowToEscape? Senior Member

    Messages:
    572
    Likes:
    761
    A pre-clinical study is a long way from proof that this stuff is effective for the treatment of any disease, much less one one understands. Hope it pans out, don’t hold your breath.
     

See more popular forum discussions.

Share This Page